National Guideline Clearinghouse | Panobinostat for treating multiple myeloma after at least 2 previous treatments.

National Guideline Clearinghouse | Panobinostat for treating multiple myeloma after at least 2 previous treatments.

National Institute for Health and Care Excellence (NICE)

• Panobinostat for treating multiple myeloma after at least 2 previous treatments.

Guideline Title Panobinostat for treating multiple myeloma after at least 2 previous treatments. Bibliographic Source(s) National Institute for Health and Care Excellence (NICE). Panobinostat for treating multiple myeloma after at least 2 previous treatments. London (UK): National Institute for Health and Care Excellence (NICE); 2016 Jan 27. 30 p. (Technology appraisal guidance; no. 380).  Guideline Status This is the current release of the guideline. This guideline meets NGC's 2013 (revised) inclusion criteria.